# FDA Inspection 1202239 - Mark A. Lomaga, M.D., Ph.D. - March 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/mark-a-lomaga-md-phd/3c3f7ca8-024d-416c-afa6-223e10ee014c
Source feed: FDA_Inspections

> FDA Inspection 1202239 for Mark A. Lomaga, M.D., Ph.D. on March 31, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202239
- Company Name: Mark A. Lomaga, M.D., Ph.D.
- Inspection Date: 2023-03-31
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/mark-a-lomaga-md-phd/09eca86a-a51d-4ae7-943e-74f79ff94290

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c